Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Staphylococcus and Neisseria Tablets on Clinical Outcome Among Patients With Chronic Obstructive Pulmonary Disease: A Multi-center, Prospective Study

NCT05975788 is registered in ClinicalTrials.gov with Peking University Third Hospital as lead sponsor.

NCT NCT05975788
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05975788 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Staphylococcus and Neisseria Tablets on Clinical Outcome Among Patients With Chronic Obstructive Pulmonary Disease: A Multi-center, Prospective Study
Lead sponsor
Peking University Third Hospital
Phase
Phase 4
Overall status
Unknown status
Start date
November 30, 2023
Completion date
July 31, 2025
Enrollment
750 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic obstructive pulmonary disease